IP Library › Granted Patent US 10,927,407
Granted Patent B2
US 10,927,407 · App. 16/022,360 · Granted Feb 23, 2021

Systems and methods for handling microfluidic droplets

Inventor: Darren Roy Link (Lexington, MA)
Assignee: Bio-Rad Laboratories, Inc.
C12Q1/6848B01F3/0807B01F13/0062B01J19/0093B01L3/502715B01L3/502753B01L3/502776B01L3/502784B01L3/565B03C5/005B03C5/026C12N15/1075C12Q1/00C12Q1/6806C12Q1/686C12Q1/6827C12Q1/6844C12Q1/6874G01N1/38G01N15/147G01N35/08B01J2219/0086B01J2219/0097B01J2219/00783B01J2219/00788B01J2219/00828B01J2219/00831B01J2219/00833B01J2219/00837B01J2219/00853B01J2219/00869B01J2219/00889B01J2219/00903B01J2219/00988B01L3/502746B01L7/525B01L9/527B01L2200/027B01L2200/0636B01L2200/0647B01L2200/0673B01L2200/10B01L2200/141B01L2300/0636B01L2300/0816B01L2300/0861B01L2300/0864B01L2300/0867B01L2300/165B01L2400/0415B01L2400/0424B01L2400/0487B01L2400/086B03C2201/26C12Q2525/191C12Q2535/101C12Q2563/149C12Q2563/159C12Q2565/628C12Q2565/629G01N2035/00158G01N2035/00237G01N2035/00326
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,927,407
App. No.
16/022,360
Granted
Feb 23, 2021
Kind
B2
Abstract

The invention generally relates to assemblies for displacing droplets from a vessel that facilitate the collection and transfer of the droplets while minimizing sample loss. In certain aspects, the assembly includes at least one droplet formation module, in which the module is configured to form droplets surrounded by an immiscible fluid. The assembly also includes at least one chamber including an outlet, in which the chamber is configured to receive droplets and an immiscible fluid, and in which the outlet is configured to receive substantially only droplets. The assembly further includes a channel, configured such that the droplet formation module and the chamber are in fluid communication with each other via the channel. In other aspects, the assembly includes a plurality of hollow members, in which the hollow members are channels and in which the members are configured to interact with a vessel.

Claims (26)

1. A system for analyzing a haplotype of a nucleic acid, the system comprising:

a first assembly comprising

a first microfluidic channel on a microfluidic chip comprising a flow of nucleic acids and loci-specific primers in an aqueous fluid,

a second microfluidic channel on the microfluidic chip that connects to the first microfluidic channel at a junction, the second microfluidic channel comprising a stream of oil, and

a third microfluidic channel downstream of the junction comprising a plurality of aqueous droplets surrounded by the oil, wherein at least one droplet of the plurality of aqueous droplets comprises a single nucleic acid and a loci-specific primer pair specific to a segment of nucleic acid that includes two or more variant loci;

an off-chip reservoir in fluid communication with the third microfluidic channel to pool the plurality of aqueous droplets and expose the plurality of aqueous droplets to thermocycling to produce amplicons that includes the two or more variant loci in the droplet;

a second assembly comprising one or more channels operable to remove droplets from the off-chip reservoir and into a second assembly main channel; and

an analysis module connected to the second assembly main channel and operable to analyze the amplicons.

2. The system of claim 1 , wherein the first microfluidic channel is configured to combine the nucleic acids and loci-specific primers in the aqueous fluid under microfluidic control.

3. The system of claim 1 , the second assembly further comprising a module for collecting the amplicons from the plurality of aqueous droplets.

4. The system of claim 1 , wherein the analysis module analyzes the amplicons to determine a haplotype of the nucleic acid.

5. The system of claim 4 , wherein analyzing comprises detecting amplicons that originated in the same droplet.

6. The system of claim 4 , wherein analyzing comprises sequencing.

7. The system of claim 1 , wherein the nucleic acids are bound to a substrate.

8. The system of claim 7 , wherein the substrate is a bead.

9. The system of claim 1 , wherein the nucleic acids are obtained from blood, urine, cerebrospinal fluid, seminal fluid, saliva, sputum, stool, or tissue of an organism.

10. The system of claim 1 , wherein the nucleic acids comprise genomic DNA, cDNA, or RNA.

11. The system of claim 1 , wherein the aqueous fluid further comprises a polymerase and a plurality of deoxynucleotides.

12. The system of claim 1 , wherein the loci-specific primers are designed to minimize bias.

13. The system of claim 1 , wherein the oil comprises a surfactant.

14. The system of claim 4 , wherein detecting a haplotype correlates to detecting a disease.

15. The system of claim 14 , wherein the disease is cancer, and wherein the loci-specific primers are configured to hybridize to loci associated with known cancer biomarkers.

16. The system of claim 1 , wherein the off-chip reservoir comprises vessel that is pre-fitted to an output of the first assembly.

17. The system of claim 16 , wherein the vessel is connectable to the second assembly.

18. The system of claim 1 , wherein the vessel is a PCR tube, vial, or test tube.

19. The system of claim 18 , wherein the first assembly includes a device that brings a rim of the vessel into contact with the first assembly, and the second assembly includes: a second device that sealably connects the vessel to the second assembly; and a hollow member that drives oil into the vessel to displace droplets from the vessel.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2019
From: RAINDANCE TECHNOLOGIES, INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 049621/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2018
From: LINK, DARREN ROY
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 046448/0471 →
Continuity (38)
Continuation 15863496 · Jan 5, 2018
Continuation 15415044 · Jan 25, 2017
Continuation 13855318 · Apr 2, 2013
Continuation In Part 13026120 · Feb 11, 2011
Continuation In Part 12504764 · Jul 17, 2009
Continuation In Part 11803104 · May 11, 2007
Provisional Application 61388937 · Oct 1, 2010
Provisional Application 61347158 · May 21, 2010
Provisional Application 61331490 · May 5, 2010
Provisional Application 61304163 · Feb 12, 2010
Provisional Application 61081930 · Jul 18, 2008
Provisional Application 60920337 · Mar 26, 2007
Provisional Application 60904293 · Feb 28, 2007
Provisional Application 60903153 · Feb 23, 2007
Provisional Application 60899258 · Feb 2, 2007
Provisional Application 60876209 · Dec 20, 2006
Provisional Application 60874640 · Dec 12, 2006
Provisional Application 60874561 · Dec 12, 2006
Provisional Application 60876766 · Dec 8, 2006
Provisional Application 60860665 · Nov 22, 2006
Provisional Application 60858279 · Nov 8, 2006
Provisional Application 60858278 · Nov 8, 2006
Provisional Application 60856540 · Nov 3, 2006
Provisional Application 60856440 · Nov 3, 2006
Provisional Application 60843374 · Sep 8, 2006
Provisional Application 60843327 · Sep 8, 2006
Provisional Application 60841716 · Sep 1, 2006
Provisional Application 60837871 · Aug 14, 2006
Provisional Application 60837695 · Aug 14, 2006
Provisional Application 60834987 · Jul 31, 2006
Provisional Application 60833151 · Jul 24, 2006
Provisional Application 60819733 · Jul 7, 2006
Provisional Application 60819734 · Jul 7, 2006
Provisional Application 60815097 · Jun 19, 2006
Provisional Application 60808614 · May 25, 2006
Provisional Application 60799833 · May 11, 2006
Provisional Application 60799834 · May 11, 2006
Related Publication 20180305747A1 · Oct 25, 2018
Cited By (11)
US 12,252,745 US 12,265,088 US 12,270,815 US 12,319,964 US 12,337,287 US 12,454,718 US 12,461,094 US 12,529,097 US 12,540,948 US 12,631,651 US 12,663,356